Britain's Creo receives speedy FDA approval for its endoscopic device

LONDON (Reuters) - Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news